Skip to content
The Chat Archive
gpt-4-0613· OpenAI Arena Human Preference 55K

trial by Elgazzar et al

  1. User

    trial by Elgazzar et al

  2. Assistant

    The trial by Elgazzar et al is a study titled "Efficacy and Safety of Ivermectin for Treatment and prophylaxis of COVID-19 Pandemic" that was published in 2020. The study aimed to evaluate the effectiveness of Ivermectin, an anti-parasitic drug, in treating and preventing COVID-19. However, it's important to note that this paper was withdrawn by the journal due to concerns over the data and ethical approval.

    The trial reported positive outcomes for patients treated with Ivermectin, but it has been subject to much scrutiny and criticism by the scientific community. The data integrity and ethical conduct of the trial have been questioned, leading to the withdrawal of the paper from the journal where it was initially published. As of now, the use of Ivermectin for COVID-19 is not widely endorsed due to lack of robust, high-quality evidence.

Responses were produced in different, uncontrolled contexts (system prompts, settings, prior turns). This is not a benchmark.